The Journal of infectionHumansCRISPR-Cas SystemsAdenovirusesHumanVirus Replication
High-efficiency inhibition of human adenovirus type 55 replication by CRISPR-Cas12a.
Lifang Yu, Mengwei Niu, Zhuofan Dong, Xue Dong, Yao Han, Jing An, Tao Jiang, Yuehong Chen, Ye Feng, Yansong Sun, Hao Li
Published: 202510.1016/j.jinf.2025.106650
Abstract
OBJECTIVES: Human adenovirus 55 (HAdV-55), a highly pathogenic double-stranded DNA virus, presents a serious global public health challenge due to its rapid transmission and complex pathogenesis. Current antiviral treatment options for HAdV-55 are li…
Preview only. Read the full abstract at the source